Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOVER HEALTH INVESTMENTS, CORP. /DECLOV · Entity 4419 | Chief Financial Officer | January 29, 2026 | February 02, 2026 |
| INVACARE HOLDINGS CorpIVCRQ · Entity 86444 | Director | November 01, 2023 | November 03, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOVER HEALTH INVESTMENTS, CORP. /DE
Report date January 29, 2026 · Filed February 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 5,758,353 |
Reported balance
After 2026-01-29 transaction · row 1
1 source rowRow 1 · 2026-01-29 · Tax withholding · Disposed 156,856 · Balance 5,758,353 F1: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 29, 2026, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on April 29, 2024. The remaining RSUs vest in equal quarterly installments, with a final vesting date on April 29, 2028, in each case subject to the continued service of the Reporting Person on such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 29, 2026, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on April 29, 2024. The remaining RSUs vest in equal quarterly installments, with a final vesting date on April 29, 2028, in each case subject to the continued service of the Reporting Person on such vesting date.
INVACARE HOLDINGS Corp
Report date November 01, 2023 · Filed November 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 66,860 |
Reported balance
After 2023-11-01 transaction · row 1
1 source rowRow 1 · 2023-11-01 · Grant · Acquired 66,860 · Balance 66,860 F1: The restricted stock units vest in one installment on May 5, 2024, subject to the reporting person's continued service on the board of directors. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units vest in one installment on May 5, 2024, subject to the reporting person's continued service on the board of directors.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
OMNICELL, INC.
Report date June 15, 2023 · Filed June 16, 2023
Section 16 reporting ended · disclosed 2023-06-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 54,900 |
Reported balance
After 2023-06-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-06-15 · Tax withholding · Disposed 2,292 · Balance 54,900 F1: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. F2: The balance is adjusted to reflect 62 shares purchased under the Issuer's Employee Stock Purchase Plan on 2/15/23. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.
F2: The balance is adjusted to reflect 62 shares purchased under the Issuer's Employee Stock Purchase Plan on 2/15/23.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 18, 2021 Filed May 18, 2021 21:09 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 707 | $134.49 | $95,084.43 |
DisclosureSEC source: 0001179110-21-005513 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,142 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $133.78 to $134.49. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 23:10 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 575 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002730 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,849 F2 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 21:43 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 11,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-001586 · edgar.xml · nonDerivative · entry 3 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,713 F2 · shares: RSU: Restricted Stock Units shall vest semiannually on 6/15 and 12/15 for a period of 4 years Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 21:43 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 9,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-001586 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,363 F1 · shares: The Performance-based restricted stock unit awards vest as to 25% of the shares on the date of the Compensation Committee meeting in 2022 when the Committee reviews the performance-based metrics and determines if they were met or not with the remaining shares vesting on a semi-annual basis over a period of thirty-six months commencing on June 15, 2022 if the Company meets certain stock performance objectives compared to the NASDAQ Healthcare Index. The actual number of performance based stock awards that vest may be 0%, 50% or 100% or 150% or 200% of the numbers reflected above, depending upon the Company's performance. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 17:57 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 3,747 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-011973 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,843 F1 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 19:28 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 3,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-007410 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,590 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 19:16 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 679 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-003035 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,339 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 19:38 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 4,875 | $0.00 Strike: $36.70 | $0.00 |
DisclosureSEC source: 0001179110-20-001738 · edgar.xml · derivative · entry 10 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,875 shares Expires 2027-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 19:38 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 3,267 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-20-001738 · edgar.xml · derivative · entry 9 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,267 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 19:38 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 3,125 | $0.00 Strike: $32.78 | $0.00 |
DisclosureSEC source: 0001179110-20-001738 · edgar.xml · derivative · entry 8 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,125 shares Expires 2025-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 19:38 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 3,856 | $89.79 | $346,220.99 |
DisclosureSEC source: 0001179110-20-001738 · edgar.xml · nonDerivative · entry 6 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,018 F5 · price: The price reported in Column 4 is the average price of $89.7876. The sold price range between $90.02 to $90.38. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 19:38 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 7,411 | $89.79 | $665,415.90 |
DisclosureSEC source: 0001179110-20-001738 · edgar.xml · nonDerivative · entry 5 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,874 F4 · price: The price reported in Column 4 is the average price of $89.7876. The sold price range between $89.09 to $89.98. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 19:38 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 11,267 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-001738 · edgar.xml · nonDerivative · entry 4 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 19:38 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantStock Options NQ (Right to Buy) · Derivative | 25,618 | $0.00 Strike: $90.19 | $0.00 |
DisclosureSEC source: 0001179110-20-001738 · edgar.xml · derivative · entry 7 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,618 Underlying: Common Stock · 25,618 shares Expires 2030-02-12 F3 · shares: NQ: Shares shall vest ratably over 48 month period, with a year cliff. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 19:38 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 5,987 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-001738 · edgar.xml · nonDerivative · entry 3 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,018 F2 · shares: RSU: Restricted Stock Units shall vest semiannually on 6/15 and 12/15 for a period of 4 years. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 19:38 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 6,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-001738 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,031 F1 · shares: The Performance-based restricted stock unit awards vest as to 25% of the shares on the date of the Compensation Committee meeting in 2021 when the Committee reviews the performance-based metrics and determines if they were met or not with the remaining shares vesting on a semi-annual basis over a period of thirty-six months commencing on June 15, 2021 if the Company meets certain stock performance objectives compared to the NASDAQ Healthcare Index. The actual number of performance based stock awards that vest may be 0%, 50% or 100% of the numbers reflected above, depending upon the Company's performance. Read SEC document |
| December 15, 2019 Filed Dec 16, 2019 20:03 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 3,471 | $79.69 | $276,603.99 |
DisclosureSEC source: 0001179110-19-012778 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,378 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2019 Filed Jun 17, 2019 21:22 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 4,866 | $81.03 | $394,291.98 |
DisclosureSEC source: 0001179110-19-007783 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,849 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| May 08, 2019 Filed May 8, 2019 23:56 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 20 | $82.37 | $1,647.31 |
DisclosureSEC source: 0001179110-19-005741 · edgar.xml · nonDerivative · entry 7 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,715 F4 · price: The price reported in Column 4 is the average price of $82.3654. The sold price range between $82.80 to $83.21. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 08, 2019 Filed May 8, 2019 23:56 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 994 | $82.37 | $81,871.21 |
DisclosureSEC source: 0001179110-19-005741 · edgar.xml · nonDerivative · entry 6 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,735 F3 · shares: The price reported in Column 4 is the average price of $82.3654. The sold price range between $81.00 to $81.98. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · price: The price reported in Column 4 is the average price of $82.3654. The sold price range between $82.10 to $82.79. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 08, 2019 Filed May 8, 2019 23:56 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 100 | $82.37 | $8,236.54 |
DisclosureSEC source: 0001179110-19-005741 · edgar.xml · nonDerivative · entry 5 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,729 F3 · price: The price reported in Column 4 is the average price of $82.3654. The sold price range between $81.00 to $81.98. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 07, 2019 Filed May 8, 2019 23:56 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 717 | $0.00 Strike: $36.70 | $0.00 |
DisclosureSEC source: 0001179110-19-005741 · edgar.xml · derivative · entry 11 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 717 shares Expires 2027-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2019 Filed May 8, 2019 23:56 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 8,880 | $0.00 Strike: $44.25 | $0.00 |
DisclosureSEC source: 0001179110-19-005741 · edgar.xml · derivative · entry 10 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,880 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2019 Filed May 8, 2019 23:56 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 726 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-19-005741 · edgar.xml · derivative · entry 9 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 726 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2019 Filed May 8, 2019 23:56 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 1,563 | $0.00 Strike: $32.78 | $0.00 |
DisclosureSEC source: 0001179110-19-005741 · edgar.xml · derivative · entry 8 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,563 shares Expires 2025-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2019 Filed May 8, 2019 23:56 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 9,750 | $81.34 | $793,083.53 |
DisclosureSEC source: 0001179110-19-005741 · edgar.xml · nonDerivative · entry 4 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,829 F2 · price: The price reported in Column 4 is the average price of $81.3419. The sold price range between $81.20 to $81.6675. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 07, 2019 Filed May 8, 2019 23:56 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 2,136 | $82.51 | $176,246.91 |
DisclosureSEC source: 0001179110-19-005741 · edgar.xml · nonDerivative · entry 3 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,579 F1 · price: The price reported in Column 4 is the average price of $82.5126. The sold price range between $82.25 to $82.75. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 07, 2019 Filed May 8, 2019 23:56 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 11,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005741 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to buy) · Derivative | 5,220 | $0.00 Strike: $44.25 | $0.00 |
DisclosureSEC source: 0001179110-19-003767 · edgar.xml · derivative · entry 9 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,220 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to buy) · Derivative | 13,621 | $0.00 Strike: $36.70 | $0.00 |
DisclosureSEC source: 0001179110-19-003767 · edgar.xml · derivative · entry 8 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,621 shares Expires 2027-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to buy) · Derivative | 2,345 | $0.00 Strike: $32.78 | $0.00 |
DisclosureSEC source: 0001179110-19-003767 · edgar.xml · derivative · entry 7 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,345 shares Expires 2025-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to buy) · Derivative | 1,094 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-19-003767 · edgar.xml · derivative · entry 6 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,094 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 13,379 | $84.07 | $1,124,771.19 |
DisclosureSEC source: 0001179110-19-003767 · edgar.xml · nonDerivative · entry 5 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,873 F4 · price: The price reported in Column 4 is the average price of $84.0699. The sold price range between $84.00 to $84.71. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 12, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 8,901 | $84.07 | $748,306.18 |
DisclosureSEC source: 0001179110-19-003767 · edgar.xml · nonDerivative · entry 4 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,252 F3 · price: The price reported in Column 4 is the average price of $84.0699. The sold price range between $83.02 to $83.98. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 12, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 22,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003767 · edgar.xml · nonDerivative · entry 3 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2019 Filed Mar 12, 2019 22:40 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 2,224 | $83.00 | $184,592.00 |
DisclosureSEC source: 0001179110-19-003767 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,873 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F1 · price: The price reported in Column 4 is the exact price of $83.00. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 00:29 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 996 | $84.27 | $83,932.92 |
DisclosureSEC source: 0001179110-19-003482 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,097 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| February 13, 2019 Filed Feb 16, 2019 00:48 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantStock Option (Right to Buy) · Derivative | 28,708 | $0.00 Strike: $78.91 | $0.00 |
DisclosureSEC source: 0001179110-19-002027 · edgar.xml · derivative · entry 4 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,708 Underlying: Common Stock · 28,708 shares Expires 2029-02-12 F2 · shares: Shares shall vest ratably over 48 month period, with a year cliff. Read SEC document |
| February 13, 2019 Filed Feb 16, 2019 00:48 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 6,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-002027 · edgar.xml · nonDerivative · entry 3 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,093 F1 · shares: Restricted Stock Units shall vest semiannually on 6/15 and 12/15 for a period of 4 years. Read SEC document |
| February 13, 2019 Filed Feb 16, 2019 00:48 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 7,865 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-002027 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,250 F3 · shares: The Performance-based restricted stock unit awards vest as to 25% of the shares on the date of the Compensation Committee meeting in 2020 when the Committee reviews the performance-based metrics and determines if they were met or not with the remaining shares vesting on a semi-annual basis over a period of thirty-six months commencing on June 15, 2020 if the Company meets certain stock performance objectives compared to the NASDAQ Healthcare Index. The actual number of performance based stock awards that vest may be 0%, 50% or 100% of the numbers reflected above, depending upon the Company's performance. Read SEC document |
| December 18, 2018 Filed Dec 18, 2018 22:49 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 2,429 | $64.18 | $155,898.32 |
DisclosureSEC source: 0001179110-18-014082 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,385 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F1 · price: The price reported in Column 4 is the average price of $64.1821. The shares sold between $63.65 to $64.69. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 15, 2018 Filed Dec 17, 2018 22:47 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 2,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-013984 · edgar.xml · nonDerivative · entry 3 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,814 Read SEC document |
| December 15, 2018 Filed Dec 17, 2018 22:47 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 1,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-013984 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,231 F1 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| December 10, 2018 Filed Dec 10, 2018 23:38 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 1,884 | $0.00 Strike: $36.70 | $0.00 |
DisclosureSEC source: 0001179110-18-013647 · edgar.xml · derivative · entry 10 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,884 Underlying: Common Stock · 1,884 shares Expires 2027-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| December 10, 2018 Filed Dec 10, 2018 23:38 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 261 | $0.00 Strike: $36.70 | $0.00 |
DisclosureSEC source: 0001179110-18-013647 · edgar.xml · derivative · entry 9 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261 Underlying: Common Stock · 261 shares Expires 2027-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| December 10, 2018 Filed Dec 10, 2018 23:38 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 1,086 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-18-013647 · edgar.xml · derivative · entry 8 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,086 Underlying: Common Stock · 1,086 shares Expires 2027-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| December 10, 2018 Filed Dec 10, 2018 23:38 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 2,343 | $0.00 Strike: $32.78 | $0.00 |
DisclosureSEC source: 0001179110-18-013647 · edgar.xml · derivative · entry 7 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,373 Underlying: Common Stock · 2,343 shares Expires 2025-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| December 10, 2018 Filed Dec 10, 2018 23:38 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 1,884 | $70.12 | $132,113.05 |
DisclosureSEC source: 0001179110-18-013647 · edgar.xml · nonDerivative · entry 6 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,542 F5 · price: The price reported in Column 4 is the average price of $70.1237. The sold price range was between $69.20 to $71.43. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 10, 2018 Filed Dec 10, 2018 23:38 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 261 | $69.78 | $18,212.58 |
DisclosureSEC source: 0001179110-18-013647 · edgar.xml · nonDerivative · entry 5 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,426 F4 · price: The price reported in Column 4 is the exact price of $69.78. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 10, 2018 Filed Dec 10, 2018 23:38 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 1,086 | $70.13 | $76,163.13 |
DisclosureSEC source: 0001179110-18-013647 · edgar.xml · nonDerivative · entry 4 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,687 F3 · price: The price reported in Column 4 is the average price of $70.1318. The sold price range was between $69.20 to $71.39. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.